Boston Scientific is confident it will be the first company to offer a “modular” cardiac rhythm management (mCRM) system with a separate pacemaker and implantable cardioverter defibrillator (ICD) that can wirelessly communicate with each other and work together to manage arrhythmias.
Boston Scientific’s mCRM System consists of its established Emblem MRI subcutaneous implantable defibrillator (S-ICD) system and its Empower MPS leadless pacemaker, which is designed to be the first leadless pacemaker that can deliver both
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?